Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the great news about Ebola in Uganda. She also covers COVID-19 news, and what it has to do with the Clash of the Titans.
Uganda Declares Ebola Outbreak Over!
Very good and exciting news – the outbreak of Ebola Sudan has officially been declared over in Uganda. Four months of containment efforts helped keep the cases at 143 and deaths at 55. First identified in September, this is the eighth outbreak the country has experienced since 2000. The director-general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, “praised Uganda for its response to the virus. ‘Uganda has shown that Ebola can be defeated when the whole system works together, from having an alert system in place, to finding and caring for people affected and their contacts, to gaining the full participation of affected communities in the response,’ he said in a statement.”
Ebola outbreaks will continue to occur, stressing public health efforts, but the capacity for rapid response and international support speaks to our increasing skills in containment and collaboration.
What’s Going on With COVID-19?
We couldn’t have a “Hot Topics in IPC” without addressing the coronavirus in the room, right? As January is in full swing, it appears we may have avoided a harsh COVID-19 surge this winter. I’m surprised, as I think so many infection prevention specialists were, given the lax public health restrictions and sluggish desire for boosters. Cases are currently down 2% in the United States within the last 2 weeks, with a daily average of 63,000 cases. Test positivity is up 8%, hovering around 15%, and roughly 46,000 people a day are hospitalized with COVID-19 in the US, which is an increase of 12% in the last 2 weeks.
Immune system evasion and a high transmission capacity mean that scientists are closely watching XBB1.5.
Frustratingly, deaths are higher, sitting at 555 per day, which is an increase of 61%. If we look at a state-by-state example, Florida is seeing a spike in cases and is up by 90%, whereas California’s cases are down 33%. The US is a patchwork of both dropping and rising cases, with some states showing improvements. Washington, DC had a 53% decline in cases, whereas Alaska is experiencing an increase and has seen a 43% rise in cases.
Many conversations in the media and infection prevention circles have centered around the latest variant–a subvariant of Omicron called XBB1.5, which some individuals have dubbed “Kracken,” which isn’t very scientific. While XBB1.5 is rapidly spreading and is considered to be very transmissible, we’re still learning about how this new subvariant will behave. “By contrast, XBB.1.5’s defining feature and its main difference from XBB is a spike protein mutation known as F486P. This mutation gives XBB.1.5 a significant advantage, boosting infectivity while retaining XBB’s ability to sneak past human defenses. In other words, it’s less of a trade-off and more of a turbocharge.” Immune system evasion and a high transmission capacity mean that scientists are closely watching XBB1.5.
However, much of the hysteria is unnecessary and should be met with skepticism—including calling the subvariant “Kracken.” While it is a worrisome variant, it’s not one that entirely evades our immune system. As Jacob Stern noted, “For Stephen Goldstein, an evolutionary virologist at the University of Utah, the new names are not just unnecessary but potentially harmful. ‘It’s absolutely crazy that we’re having random people on Twitter name variants,’ he told me. For Goldstein, dressing up each new subvariant with an ominous monster name overplays the differences between the mutations and feeds into the panic that comes every time the coronavirus shifts form. In this view, distinguishing one Omicron sublineage from another is less like distinguishing a wolf from a cow and more like distinguishing a white-footed mouse from a deer mouse: important to a rodentologist but not really to anyone else.” In short, if “Kracken” is on the brain, perhaps turn to Clash of the Titans rather than the latest COVID-19 news.
P.S. Did you listen to music during COVID-19 lockdowns? Odds are, you had an improved mood!
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.